CClinicalTrials.gg
Status unknownNCT00383773Updated Oct 4, 2006

Retinal Endo Vascular Surgery for Central Retinal Vein Occlusion

An interventional study of Retinal endo vascular surgery in Central Retinal Vein Occlusion, sponsored by Hadassah Medical Organization. Status unknown. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2006-10-04.

Sponsored by Hadassah Medical Organization · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2006), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

Patients with Central Retinal Vein Occlusion will undergo vitrectomy, a small needle of about 71 micron will enter a branch retinal vein and TPA will be injected into the obstracted vein.

Read the detailed description

Patients with Central Retinal Vein Occlusion less than 6 month duration and reduction of vision to 6/21 will go OCT and FANG examinations.

Patient will be operated vitrectomy, and a branch retinal vein will be punctured by small needle and rTPA 200mcg/ml will be injected to the vein.

02

Conditions studied

  • Central Retinal Vein Occlusion

Keywords

  • retinal vein occlusion
  • rTPA
03

In context

Retinal Vein Occlusion

282 studies on the registry are indexed under Retinal Vein Occlusion; 27 are open to participants now.

This study's planned enrollment of 10 is below the median of 49 across 211 interventional studies indexed under Retinal Vein Occlusion.

Browse Retinal Vein Occlusion studies →

Lead sponsor

Hadassah Medical Organization is the lead sponsor of 659 studies on the registry; 54 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • crvo less than 6 month
  • Visual Acuity less than 6/21
  • No prior eye surgery except cataract.

Exclusion criteria

Exclusion Criteria:

  • Retinal/iris neovascularization
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Interventions

  • ProcedureRetinal endo vascular surgery
06

What researchers measure

Primary outcomes

  1. Visual acuity

  2. Amount of macular edema.

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 4, 2006, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00383773
Lead sponsor
Hadassah Medical Organization
First posted
Oct 4, 2006
Start date
Oct 2006
Completion
Oct 2007 (estimated)
Last update
Oct 4, 2006

Study contacts

Michael Halpert, MD.
Contact
halpert@cc.huji.ac.il
00972507874385
Hadas Lemberg, PhD
Contact
Ihadas@hadassah.org.il
0097226777572
Michael halpert
study chair · Hadassah Medical Organization
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2006. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion